Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acanthopanax senticosus total saponins is a Traditional Chinese Medicine (TCM) herbal extract derived from the root and rhizome of *Acanthopanax senticosus* (also known as Siberian Ginseng or Ciwujia). Developed by Wusuli River Pharmaceutical, this saponin-rich preparation is being investigated for its multi-target therapeutic effects, particularly in cardiovascular and cerebrovascular diseases, oncology, and immune system modulation. The extract is believed to enhance non-specific resistance to stressors, improve cardiovascular circulation, and exhibit anti-tumor properties through immune enhancement and direct inhibitory effects on cancer cell proliferation. It is currently in clinical development in China as an innovative drug candidate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acanthopanax senticosus total saponins.